Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium

N E FarberG J Gross


Modification of the thromboxane: prostacyclin ratio alters the severity of reperfusion arrhythmias and postischemic damage in long-term, irreversibly injured myocardium. In this study, the effects of the thromboxane synthetase inhibitor dazmegrel and the thromboxane receptor antagonist BM 13.505 on myocardial postischemic functional recovery and preservation of tissue adenine nucleotides was examined after a 15-minute episode of ischemia followed by 3 hours of reperfusion (myocardial stunning). Dazmegrel (3 or 8 mg/kg) or BM 13.505 (10 mg/kg) was given 15 minutes before coronary occlusion and compared with a control group in barbital-anesthetized dogs. Regional segment shortening (percent segment shortening, sonomicrometry), regional myocardial blood flow (microspheres), and coronary venous eicosanoid and high-energy phosphate levels (biopsies after 3 hours of reperfusion) were measured. Areas at risk, regional myocardial blood flow, and regional segment shortening during coronary occlusion were similar in all groups. Dazmegrel (3 mg/kg) attenuated the decrease in endocardial and midmyocardial adenosine 5'-triphosphate, and both doses significantly improved regional segment shortening during reperfusion. Coronary venous thrombo...Continue Reading


Jun 1, 1976·The American Journal of Physiology·T B AllisonJ C Shipp
Nov 1, 1977·Basic Research in Cardiology·M J HoskoD C Warltier
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Nov 1, 1985·Journal of Cardiovascular Pharmacology·J B KramerP B Corr
Jan 1, 1987·Journal of Cardiovascular Pharmacology·M E BrezinskiA M Lefer
Jan 6, 1987·European Journal of Pharmacology·A YanagisawaA M Lefer
Jan 20, 1987·European Journal of Pharmacology·C L Wainwright, J R Parratt
Jan 1, 1987·Prostaglandins·M E BrezinskiA M Lefer
Nov 1, 1987·American Heart Journal·N E FarberG J Gross
Jan 1, 1985·Journal of Free Radicals in Biology & Medicine·S W WernsB R Lucchesi
Jan 1, 1986·Journal of the American College of Cardiology·Y YuiC Kawai
Jan 1, 1986·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·A HoeftG Hellige
Dec 1, 1984·American Heart Journal·K Ichihara, Y Abiko


May 1, 1994·Agents and Actions·S D SethS K Maulik
Nov 7, 1989·The American Journal of Cardiology·G J GrossG M Pieper
Mar 22, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·V L SerebruanyP A Gurbel

Related Concepts

UK 38,485
SKF 96148
Coronary Circulation
Coronary Heart Disease
Canis familiaris
Energy Metabolism

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.